Stephanie Philbin

Stephanie Philbin

Counsel
Stephanie Philbin

Stephanie Philbin, a counsel in the firm’s FDA Group and a member of its Life Sciences Practice, concentrates on Food and Drug Administration laws. She joined Goodwin in 2007.

Professional Activities

Ms. Philbin is a member of the D.C. Bar Association. She is on the advisory board of BNA, Inc.’s Medical Devices Law & Industry Report.

Professional Experience

Prior to joining Goodwin, Ms. Philbin was counsel at Wilmer Cutler Pickering Hale and Dorr. Ms. Philbin is a former instructor at Georgetown University Law Center’s Foundations for Foreign Lawyers.

Recognition

While in law school, Ms. Philbin served as the Articles Editor for the Georgetown Journal of Legal Ethics.

Experience

Ms. Philbin advises clients on regulatory and compliance issues including those related to clinical trials, pre-market submissions, the Quality System Regulation, Medical Device Reporting, recalls, product importing and exporting, and product promotion. Ms. Philbin assists clients in responding to agency investigations and in filing comments with FDA to respond to various regulatory initiatives. She reviews SEC filings of FDA-regulated companies and conducts due diligence of companies as part of mergers and acquisitions and initial public offerings. Ms. Philbin also assists in litigation.

Credentials

Education

J.D., 1996
Georgetown University Law Center
B.A., 1992
College of the Holy Cross

(cum laude, Phi Beta Kappa)

Clerkships

1996 to 1997 District of Columbia Court of Appeals

Admissions

Bar

Massachusetts
District of Columbia
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Search Other Lawyers